...
首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >Ferulic acid protects lipopolysaccharide-induced acute kidney injury by suppressing inflammatory events and upregulating antioxidant defenses in Balb/c mice
【24h】

Ferulic acid protects lipopolysaccharide-induced acute kidney injury by suppressing inflammatory events and upregulating antioxidant defenses in Balb/c mice

机译:通过抑制Balb / C小鼠的抗氧化剂防御,阿魏酸通过抑制炎症事件和上调抗氧化剂防御来保护脂多糖诱导的急性肾损伤

获取原文
获取原文并翻译 | 示例

摘要

Sepsis-induced acute kidney injury (AKI) is responsible for 70-80% mortality in intensive care patients due to elevated levels of endotoxin, Lipopolysaccharide (LPS) caused by gram-negative infections. Ferulic acid (FA), a phenolic phytochemical is known for its renal protection on various induced models of nephrotoxicity. However, the curative effect of FA in LPS-induced AKI is not well studied. This study aimed to investigate the effect of FA on LPS-induced AKI in mice model and to understand the protective mechanisms involved, to provide evidence for FA in the treatment of AKI. Balb/c mice were treated with FA at 50 mg/kg and 100 mg/kg dosages after LPS stimulation (10 mg/kg). At the end of the intervention, we determined the concentrations of serum creatinine and blood urea nitrogen, inflammatory cytokines and histopathological changes in animals. Also, the relative protein expression level of TLR4 mediated NF-kappa B signaling pathway were studied in kidney tissues. FA treated animals showed upregulation of antioxidant defenses and suppression of inflammatory events by inhibiting TLR4 mediated NF kappa B activation. However, LPS alone administered group, resulted in rapid renal damage with increased levels of blood urea nitrogen and modest increase in creatinine; decreased antioxidant defenses and release of inflammatory cytokines. The histopathological analysis also revealed the protective action of the FA against sepsis induced fibrosis and renal damage. Our findings demonstrated that FA exhibits marked protective effects on LPS-induced AKI in mice suggesting its chemopotential role for treating AKI in humans.
机译:脓毒症诱导的急性肾损伤(AKI)由于内毒素的内毒素,脂多糖(LPS)水平升高,患者的重症监护患者的死亡率为70-80%。阿魏酸(Fa),酚类植物化学物质以其对各种诱导的肾毒性模型的肾脏保护而闻名。然而,FA在LPS诱导的AKI中的疗效尚未得到很好的研究。本研究旨在探讨FA对小鼠模型中LPS诱导的AKI的影响,了解所涉及的保护机制,为AKI治疗提供了FA的证据。在LPS刺激(10mg / kg)后,用50mg / kg和100mg / kg剂量处理BALB / C小鼠。在干预结束时,我们确定了动物血清肌酐和血尿尿素氮,炎症细胞因子和组织病理学变化的浓度。而且,在肾组织中研究了TLR4介导的NF-κB信令途径的相对蛋白表达水平。通过抑制TLR4介导的NFκB活化,FA处理的动物显示出抗氧化剂防御和抑制炎症事件的抑制。然而,LPS单独给药组,导致血液尿素氮水平增加的肾脏损伤,肌酐温度增加;降低抗氧化防御和炎症细胞因子的释放。组织病理学分析还揭示了对脓毒症诱导纤维化和肾损伤的保护作用。我们的研究结果表明,对小鼠的LPS诱导的AKI表现出明显的保护作用,这表明其在人类中均衡的化学功能作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号